$BLGO
BIOLARGO, INC.

2023 Q2 Form 10-Q Financial Statement

#000143774923014881 Filed on May 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $1.446M $3.742M
YoY Change 9.3% 287.77%
Cost Of Revenue $627.0K $1.932M
YoY Change -10.43% 335.14%
Gross Profit $819.0K $1.810M
YoY Change 31.46% 247.41%
Gross Profit Margin 56.64% 48.37%
Selling, General & Admin $1.791M $1.722M
YoY Change 12.71% -6.36%
% of Gross Profit 218.68% 95.14%
Research & Development $587.0K $565.0K
YoY Change 65.35% 44.13%
% of Gross Profit 71.67% 31.22%
Depreciation & Amortization $26.00K $22.00K
YoY Change 550.0% 1000.0%
% of Gross Profit 3.17% 1.22%
Operating Expenses $2.378M $2.287M
YoY Change 22.33% 2.51%
Operating Profit -$1.559M -$477.0K
YoY Change 18.02% -72.11%
Interest Expense $12.00K $48.00K
YoY Change -20.0% 269.23%
% of Operating Profit
Other Income/Expense, Net -$67.00K -$17.00K
YoY Change 458.33% -110.24%
Pretax Income -$1.626M -$494.0K
YoY Change 21.98% -68.01%
Income Tax
% Of Pretax Income
Net Earnings -$1.626M -$494.0K
YoY Change 21.98% -68.01%
Net Earnings / Revenue -112.45% -13.2%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 284.7M 283.2M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.575M $3.264M
YoY Change 191.6% 235.11%
Cash & Equivalents $3.575M $3.264M
Short-Term Investments
Other Short-Term Assets $108.0K $95.00K
YoY Change 33.33% -16.67%
Inventory $127.0K $135.0K
Prepaid Expenses
Receivables $1.037M $1.380M
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.847M $4.874M
YoY Change 126.39% 137.99%
LONG-TERM ASSETS
Property, Plant & Equipment $542.0K $391.0K
YoY Change 254.25% 334.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $21.00K $27.00K
YoY Change -36.36% -32.5%
Other Assets $69.00K $124.0K
YoY Change 0.0% 25.25%
Total Long-Term Assets $1.833M $1.773M
YoY Change 48.3% 42.87%
TOTAL ASSETS
Total Short-Term Assets $4.847M $4.874M
Total Long-Term Assets $1.833M $1.773M
Total Assets $6.680M $6.647M
YoY Change 97.81% 102.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $482.0K $1.039M
YoY Change 155.03% 56.95%
Accrued Expenses $112.0K $296.0K
YoY Change -61.9% -6.62%
Deferred Revenue $10.00K $21.00K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $66.00K $66.00K
YoY Change -18.52% -62.07%
Total Short-Term Liabilities $1.294M $1.799M
YoY Change 9.75% 44.61%
LONG-TERM LIABILITIES
Long-Term Debt $299.0K $302.0K
YoY Change 21.05% 101.33%
Other Long-Term Liabilities $721.0K $747.0K
YoY Change 152.1% 134.91%
Total Long-Term Liabilities $1.263M $1.296M
YoY Change 55.93% 100.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.294M $1.799M
Total Long-Term Liabilities $1.263M $1.296M
Total Liabilities $2.557M $3.095M
YoY Change 28.56% 63.84%
SHAREHOLDERS EQUITY
Retained Earnings -$145.2M -$143.8M
YoY Change 2.23% 2.18%
Common Stock $192.0K $190.0K
YoY Change 7.26% 7.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.368M $6.385M
YoY Change
Total Liabilities & Shareholders Equity $6.680M $6.647M
YoY Change 97.81% 102.1%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$1.626M -$494.0K
YoY Change 21.98% -68.01%
Depreciation, Depletion And Amortization $26.00K $22.00K
YoY Change 550.0% 1000.0%
Cash From Operating Activities -$1.484M -$43.00K
YoY Change 104.97% -96.23%
INVESTING ACTIVITIES
Capital Expenditures $79.00K $48.00K
YoY Change -214.49% -250.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$79.00K -$48.00K
YoY Change 14.49% 50.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.881M $1.510M
YoY Change 79.48% 26.68%
NET CHANGE
Cash From Operating Activities -1.484M -$43.00K
Cash From Investing Activities -79.00K -$48.00K
Cash From Financing Activities 1.881M $1.510M
Net Change In Cash 318.0K $1.413M
YoY Change 24.71% 11675.0%
FREE CASH FLOW
Cash From Operating Activities -$1.484M -$43.00K
Capital Expenditures $79.00K $48.00K
Free Cash Flow -$1.563M -$91.00K
YoY Change 138.63% -91.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
284122581
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
278462706
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
158000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
0 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 pure
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-19709
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0159115
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
14921 Chestnut St.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Westminster
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92683
CY2023Q1 dei City Area Code
CityAreaCode
888
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
400-2863
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock
CY2023Q1 dei Trading Symbol
TradingSymbol
BLGO
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
284690284
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3264000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1851000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1380000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1064000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
135000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
120000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
95000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
118000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4874000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3153000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
391000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
287000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
27000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
33000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
837000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
867000 usd
CY2023Q1 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
394000 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
394000 usd
CY2023Q1 us-gaap Assets
Assets
6647000 usd
CY2022Q4 us-gaap Assets
Assets
4858000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
66000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
100000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
97000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
97000 usd
CY2023Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
113000 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
184000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1799000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1576000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
302000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
237000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
747000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
773000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1296000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1271000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
3095000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2847000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
190000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
186000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
150191000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
148435000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-143841000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-143594000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-155000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-149000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
6385000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4878000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
-2833000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-2867000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3552000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2011000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6647000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4858000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3742000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
965000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1932000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
444000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
1810000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
521000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1722000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1839000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
565000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
392000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
2287000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2231000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-477000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1710000 usd
CY2023Q1 blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
0 usd
CY2022Q1 blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
174000 usd
CY2023Q1 blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
31000 usd
CY2022Q1 blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
5000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
48000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
13000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
166000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-494000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1544000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-247000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
108000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-247000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1652000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0009
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0063
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
280711278
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260805418
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-494000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1544000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-500000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1552000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-247000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
108000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-253000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1660000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2011000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
800000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
207000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
195000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
30000 usd
CY2023Q1 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-494000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3552000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
933000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1202000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
660000 usd
CY2022Q1 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
0 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1544000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1400000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-494000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1544000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
256000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
801000 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
207000 usd
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
17000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4000 usd
CY2023Q1 blgo Fair Value Of Warrant Issued For Interest
FairValueOfWarrantIssuedForInterest
30000 usd
CY2022Q1 blgo Fair Value Of Warrant Issued For Interest
FairValueOfWarrantIssuedForInterest
0 usd
CY2023Q1 blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
-0 usd
CY2022Q1 blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
174000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
22000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
2000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
316000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
178000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
29000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-25000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
59000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
4000 usd
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-89000 usd
CY2023Q1 blgo Increase Decrease In Right Of Use And Lease Liability Net
IncreaseDecreaseInRightOfUseAndLeaseLiabilityNet
4000 usd
CY2022Q1 blgo Increase Decrease In Right Of Use And Lease Liability Net
IncreaseDecreaseInRightOfUseAndLeaseLiabilityNet
0 usd
CY2023Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
71000 usd
CY2022Q1 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-12000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1140000 usd
CY2023Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
48000 usd
CY2022Q1 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
32000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
800000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1202000 usd
CY2023Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
-50000 usd
CY2022Q1 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
15000 usd
CY2022Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
10000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
225000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1510000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1192000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-6000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-8000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1413000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1851000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
962000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3264000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
974000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
15000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
7000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
5000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2023Q1 blgo Shortterm Lease Payments Not Included In Lease Liability
ShorttermLeasePaymentsNotIncludedInLeaseLiability
13000 usd
CY2022Q1 blgo Shortterm Lease Payments Not Included In Lease Liability
ShorttermLeasePaymentsNotIncludedInLeaseLiability
52000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
80000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
CY2023Q1 blgo Allocation Of Stock Option Expense Within Noncontrolling Interest
AllocationOfStockOptionExpenseWithinNoncontrollingInterest
467000 usd
CY2022Q1 blgo Allocation Of Stock Option Expense Within Noncontrolling Interest
AllocationOfStockOptionExpenseWithinNoncontrollingInterest
528000 usd
CY2023Q1 blgo Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
5 pure
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3742000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-494000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43000 usd
CY2023Q1 blgo Working Capital Deficit
WorkingCapitalDeficit
3075000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4874000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3264000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3264000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1851000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i><span style="text-decoration: underline; ">Credit Concentration</span></i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">We have a limited number of customers that account for significant portions of our revenue. During the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023, </em>one customer accounted for more than 10% of consolidated revenues, and during the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2022, </em>two customers each accounted for more than 10% of consolidated revenues:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 5%; margin-left: 18pt; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 2pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 2pt;"><b><b><b><b>March 31,</b></b></b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 2pt;"><b><b><b><b>2023</b></b></b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b><b><b>March 31,<br/> 2022</b></b></b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 68%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Customer A</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">86</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">%</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td><td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"><span style="-sec-ix-hidden:c98579630">29</span></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Customer B</p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: right;"><span style="-sec-ix-hidden:c98579631">&lt;10</span></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><span style="-sec-ix-hidden:c98579632">14</span></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">At <em style="font: inherit;"> March 31, 2023, </em>and <em style="font: inherit;"> December 31, 2022, </em>one customer accounted for more than 10% of consolidated accounts receivable:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>March 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2023</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:-5pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;text-indent:-5pt;"><b><b>2022</b></b></p> </td><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Customer A</p> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">70</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">%</td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><span style="-sec-ix-hidden:c98579634">24</span></td><td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">%</td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
158000 usd
CY2023Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
52000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
46000 usd
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
83000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
74000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
135000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
120000 usd
CY2023Q1 blgo Patents Noncurrent
PatentsNoncurrent
34000 usd
CY2022Q4 blgo Patents Noncurrent
PatentsNoncurrent
34000 usd
CY2023Q1 blgo Security Deposits Noncurrent
SecurityDepositsNoncurrent
36000 usd
CY2022Q4 blgo Security Deposits Noncurrent
SecurityDepositsNoncurrent
36000 usd
CY2023Q1 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
54000 usd
CY2022Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
54000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124000 usd
CY2022Q4 blgo Finitelived Tangible Assets Net
FinitelivedTangibleAssetsNet
3958000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;"><b><i><span style="text-decoration: underline; ">Use of Estimates </span></i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and revenues and expenses during the period reported. Actual results could differ from those estimates. Estimates are used when accounting for stock-based transactions, debt transactions, derivative liabilities, allowance for bad debt, asset depreciation and amortization, impairment expense, among others.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The methods, estimates and judgments we use in applying these most critical accounting policies have a significant impact on the results of our financial statements.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
8000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
867000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.18 pure
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.18 pure
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
837000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
844000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000 usd
CY2023Q1 blgo Finitelived Tangible Assets Net
FinitelivedTangibleAssetsNet
5783000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
-0 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
3000 usd
CY2023Q1 us-gaap Debt Current
DebtCurrent
66000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
100000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
302000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
237000 usd
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
368000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
337000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
48000 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
13000 usd
CY2023Q1 us-gaap Share Price
SharePrice
0.20
CY2023Q1 us-gaap Share Price
SharePrice
0.20
CY2023Q1 us-gaap Share Price
SharePrice
0.20
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
49023398
CY2023Q1 blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
7512000
CY2023Q1 blgo Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
4684986
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
51850412
CY2023Q1 blgo Class Of Warrant Or Right Aggregate Value Of Warrants Or Rights
ClassOfWarrantOrRightAggregateValueOfWarrantsOrRights
122000 usd
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
36765562
CY2022Q1 blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
10393936
CY2022Q1 blgo Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
388889
CY2022Q1 blgo Price Range Warrants Expired
PriceRangeWarrantsExpired
0.22
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
46770549
CY2023Q1 us-gaap Share Price
SharePrice
0.20
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
837000 usd
CY2023Q1 blgo Tangible And Intangible Assets Rightofuse Assets And Equity Method Investment Total
TangibleAndIntangibleAssetsRightofuseAssetsAndEquityMethodInvestmentTotal
6647000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1039000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
160000 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
25000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1224000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
717000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
198000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
25000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
940000 usd
CY2019Q4 blgo Percentage Of Profits Interests Vested
PercentageOfProfitsInterestsVested
0.025 pure
CY2019Q4 blgo Percentage Of Option To Purchase Shares Of Common Stock
PercentageOfOptionToPurchaseSharesOfCommonStock
0.10 pure
CY2021Q1 blgo Percentage Of Profits Interests Vested
PercentageOfProfitsInterestsVested
0.0375 pure
CY2021Q1 blgo Percentage Of Option To Purchase Shares Of Common Stock
PercentageOfOptionToPurchaseSharesOfCommonStock
0.15 pure
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3742000 usd
CY2023Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
565000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-477000 usd
CY2023Q1 blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
31000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
48000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-494000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
965000 usd
CY2022Q1 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
0 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
392000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1710000 usd
CY2022Q1 blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
5000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
13000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1544000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4858000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
83000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
63000 usd
CY2023Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.18 pure

Files In Submission

Name View Source Status
0001437749-23-014881-index-headers.html Edgar Link pending
0001437749-23-014881-index.html Edgar Link pending
0001437749-23-014881.txt Edgar Link pending
0001437749-23-014881-xbrl.zip Edgar Link pending
blgo-20230331.xsd Edgar Link pending
blgo20230331_10q.htm Edgar Link pending
ex_514994.htm Edgar Link pending
ex_514995.htm Edgar Link pending
ex_514996.htm Edgar Link pending
ex_521371.htm Edgar Link pending
ex_521372.htm Edgar Link pending
ex_521373.htm Edgar Link pending
blgo-20230331_lab.xml Edgar Link unprocessable
blgo-20230331_pre.xml Edgar Link unprocessable
blgo-20230331_cal.xml Edgar Link unprocessable
blgo-20230331_def.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
blgo20230331_10q_htm.xml Edgar Link completed